PONTI, Antonio, Elsebeth LYNGE, Ted JAMES, Ondřej MÁJEK, My von EULER-CHELPIN, Ahti ANTTILA, Patricia FITZPATRICK, Maria Piera MANO, Masaaki KAWAI, Astrid SCHARPANTGEN, Jacques FRACHEBOUD, Solveig HOFVIND, Carmen VIDAL, Nieves ASCUNCE, Dolores SALAS, Jean-Luc BULLIARD, Nereo SEGNAN, Karla KERLIKOWSKE a Stephen TAPLIN. International variation in management of screen-detected ductal carcinoma in situ of the breast. European Journal of Cancer. Oxford: Elsevier Science Ltd., roč. 50, č. 15, s. 2695-2704. ISSN 0959-8049. doi:10.1016/j.ejca.2014.07.019. 2014.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název International variation in management of screen-detected ductal carcinoma in situ of the breast
Autoři PONTI, Antonio (380 Itálie), Elsebeth LYNGE (276 Německo), Ted JAMES (840 Spojené státy), Ondřej MÁJEK (203 Česká republika, garant, domácí), My von EULER-CHELPIN (276 Německo), Ahti ANTTILA (246 Finsko), Patricia FITZPATRICK (372 Irsko), Maria Piera MANO (380 Itálie), Masaaki KAWAI (392 Japonsko), Astrid SCHARPANTGEN (442 Lucembursko), Jacques FRACHEBOUD (528 Nizozemské království), Solveig HOFVIND (578 Norsko), Carmen VIDAL (724 Španělsko), Nieves ASCUNCE (724 Španělsko), Dolores SALAS (203 Česká republika), Jean-Luc BULLIARD (756 Švýcarsko), Nereo SEGNAN (380 Itálie), Karla KERLIKOWSKE (840 Spojené státy) a Stephen TAPLIN (840 Spojené státy).
Vydání European Journal of Cancer, Oxford, Elsevier Science Ltd. 2014, 0959-8049.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30200 3.2 Clinical medicine
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 5.417
Kód RIV RIV/00216224:14110/14:00077347
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1016/j.ejca.2014.07.019
UT WoS 000342699300018
Klíčová slova anglicky Breast cancer; Ductal carcinoma in situ (DCIS); Screening mammography; Overtreatment; Axillary staging; Cancer registration
Štítky EL OK
Příznaky Mezinárodní význam
Změnil Změnila: Soňa Böhmová, učo 232884. Změněno: 18. 11. 2014 14:22.
Anotace
Background: Ductal carcinoma in situ (DCIS) incidence has grown with the implementation of screening and its detection varies across International Cancer Screening Network (ICSN) countries. The aim of this survey is to describe the management of screen-detected DCIS in ICSN countries and to evaluate the potential for treatment related morbidity. Methods: We sought screen-detected DCIS data from the ICSN countries identified during 2004-2008. We adopted standardised data collection forms and analysis and explored DCIS diagnosis and treatment processes ranging from pre-operative diagnosis to type of surgery and radiotherapy. Results: Twelve countries contributed data from a total of 15 screening programmes, all from Europe except the United States of America and Japan. Among women aged 50-69 years, 7,176,050 screening tests and 5324 screen-detected DCIS were reported. From 21% to 93% of DCIS had a pre-operative diagnosis (PO); 67-90% of DCIS received breast conservation surgery (BCS), and in 41-100% of the cases this was followed by radiotherapy; 6.4-59% received sentinel lymph node biopsy (SLNB) only and 0.8-49% axillary dissection (ALND) with 0.6% (range by programmes 0-8.1%) being node positive. Among BCS patients 35% received SLNB only and 4.8% received ALND. Starting in 2006, PO and SLNB use increased while ALND remained stable. SLNB and ALND were associated with larger size and higher grade DCIS lesions. Conclusions: Variation in DCIS management among screened women is wide and includes lymph node surgery beyond what is currently recommended. This indicates the presence of varying levels of overtreatment and the potential for its reduction.
VytisknoutZobrazeno: 19. 4. 2024 06:16